% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • ytodd36 ytodd36 Mar 25, 2013 4:05 PM Flag

    Acadia shares rise as analyst sees drug approval/ Jefferies Initiates $13 ON ACAD. LINKED

    Acadia shares rise as analyst sees drug approval
    Shares of Acadia Pharma jump on confidence a top drug candidate will be approved
    Associated PressAssociated Press –
    NEW YORK (AP) -- Shares of Acadia Pharmaceuticals Inc. rose Monday on investor optimism about the prospects for its drug candidate pimavanserin, which is designed to treat psychosis in patients with Parkinson's disease.
    Jefferies analyst Thomas Wei backed his "Buy" rating and $13 price target for the stock, saying that overall feedback on new data from a study of pimavanserin has been positive. The analyst said Jefferies spoke with 28 neurologists about the drug at a recent conference.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
19.36-0.93(-4.58%)Feb 5 4:00 PMEST